                               SEQUENCE LISTING

<110> FLAGSHIP PIONEERING, INC.
 
<120> METHODS AND COMPOSITIONS FOR MODULATING CELLS AND CELLULAR 
      MEMBRANES

<130> F2109-7000W0

<140> PCT/US2021/038087
<141> 2021-06-18

<150> 63/040,860
<151> 2020-06-18

<160> 39    

<170> PatentIn version 3.5

<210> 1

<400> 1
000


<210> 2
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 2
Met Arg Val Lys Glu Lys Tyr Gln His Leu Trp Arg Trp Gly Trp Lys 
1               5                   10                  15      


Trp Gly Thr Met Leu Leu Gly Ile Leu Met Ile Cys Ser Ala Thr Glu 
            20                  25                  30          


<210> 3
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 3
Cys Ala Ala Leu 
1               


<210> 4
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 4
Lys Lys Lys Lys Lys Lys 
1               5       


<210> 5
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 5
Arg Arg Arg Arg Arg 
1               5   


<210> 6
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 6
Met Arg Leu Leu Leu Ala Leu Leu Gly Val Leu Leu Ser Val Pro Gly 
1               5                   10                  15      


Pro Pro Val Leu Ser 
            20      


<210> 7
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 7
Cys Ser Ile Met Asn Leu Met Cys Gly Ser Thr Cys 
1               5                   10          


<210> 8
<211> 45
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 8
Gly His Lys Ser Glu Glu Lys Arg Glu Lys Met Lys Arg Thr Leu Leu 
1               5                   10                  15      


Lys Asp Trp Lys Thr Arg Leu Ser Tyr Phe Leu Gln Asn Ser Ser Thr 
            20                  25                  30          


Pro Gly Lys Pro Lys Thr Gly Lys Lys Ser Lys Gln Gln 
        35                  40                  45  


<210> 9
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 9
Arg Ser Thr Leu Lys Leu Thr Thr Leu Gln Cys Gln Tyr Ser Thr Val 
1               5                   10                  15      


Met Asp 
        


<210> 10
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 10
Arg Gln Gly Leu His Asn Met Glu Asp Val Tyr Glu Leu Ile Glu Asn 
1               5                   10                  15      


Ser His 
        


<210> 11
<211> 30
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 11
Met Asp Cys Arg Lys Met Ala Arg Phe Ser Tyr Ser Val Ile Trp Ile 
1               5                   10                  15      


Met Ala Ile Ser Lys Val Phe Glu Leu Gly Leu Val Ala Gly 
            20                  25                  30  


<210> 12
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 12
Met Pro Ala Trp Gly Ala Leu Phe Leu Leu Trp Ala Thr Ala Glu Ala 
1               5                   10                  15      


<210> 13
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 13
Arg Asp Tyr Arg 
1               


<210> 14
<211> 55
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 14
Lys Met Ala Leu Arg Val Ala Leu Asn Asn Lys Gln Ser Gly Gln Ile 
1               5                   10                  15      


Thr Val Lys Thr Ser Ser Ser Asp His Leu Ser Leu Ala Ile Ala Gly 
            20                  25                  30          


Leu Val Pro Ile Ala Leu Ser Ile Tyr Gln Lys Phe Lys Pro Gly Val 
        35                  40                  45              


Ser Pro Ser Tyr Ser Ile Tyr 
    50                  55  


<210> 15
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 15
Met Gly Ser Lys Ile Val Gln Val Phe Leu Met Leu Ala Leu Phe Ala 
1               5                   10                  15      


Thr Ser Ala Leu Ala 
            20      


<210> 16
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 16
Met Asn Ser Lys Ala Met Gln Ala Leu Ile Phe Leu Gly Phe Leu Ala 
1               5                   10                  15      


Thr Ser Cys Leu Ala 
            20      


<210> 17
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 17
Met Gly Ala Ala Ala Ser Ile Gln Thr Thr Val Asn 
1               5                   10          


<210> 18
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 18
Phe Ala Leu Leu Gly Thr His Gly Ala Ser Gly 
1               5                   10      


<210> 19
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 19
Arg Arg Arg Thr Phe Leu Lys 
1               5           


<210> 20
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 20
Met Gly Gly Lys Trp Ser Lys Ser Ser Val 
1               5                   10  


<210> 21
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 21
Asp Asp Pro Glu Arg Glu 
1               5       


<210> 22
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 22
Glu Glu Ala Asn Thr Gly Glu Asn Asn Ser Leu Leu His Pro Met Ser 
1               5                   10                  15      


<210> 23
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 23
Ser Arg Arg Gly Leu Val 
1               5       


<210> 24
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 24
Ser Arg Arg Arg Phe Leu 
1               5       


<210> 25
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 25
Ser Arg Arg Gln Phe Ile 
1               5       


<210> 26
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 26
Gln Arg Arg Asp Phe Leu 
1               5       


<210> 27
<211> 52
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 27
Met Asn Lys Ile Tyr Ser Ile Lys Tyr Ser Ala Ala Thr Gly Gly Leu 
1               5                   10                  15      


Ile Ala Val Ser Glu Leu Ala Lys Lys Val Ile Cys Lys Thr Asn Arg 
            20                  25                  30          


Lys Ile Ser Ala Ala Leu Leu Ser Leu Ala Val Ile Ser Tyr Thr Asn 
        35                  40                  45              


Ile Ile Tyr Ala 
    50          


<210> 28
<211> 40
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 28
Met Asn Pro Asn Gln Lys Ile Ile Thr Ile Gly Ser Ile Cys Met Val 
1               5                   10                  15      


Ile Gly Ile Val Ser Leu Met Leu Gln Ile Gly Asn Ile Ile Ser Ile 
            20                  25                  30          


Trp Val Ser His Ser Ile Gln Thr 
        35                  40  


<210> 29
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 29
Leu Arg Cys Leu Ala Cys Ser Cys Phe Arg Thr Pro Val Trp Pro Arg 
1               5                   10                  15      


<210> 30
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 30
Met Gly Cys Gly Cys Ser Ser His Pro Glu 
1               5                   10  


<210> 31
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 31
Met Pro Phe Val Asn Lys Gln Phe Asn 
1               5                   


<210> 32
<211> 28
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 32
Asp Glu Gln Asn Ala Lys Asn Ala Ala Gln Asp Arg Asn Ser Asn Lys 
1               5                   10                  15      


Ser Ser Lys Gly Phe Phe Ser Lys Leu Gly Cys Cys 
            20                  25              


<210> 33
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 33
Met Leu Cys Cys Met Arg Arg Thr Lys Gln 
1               5                   10  


<210> 34
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 34
Val Thr Asn Gly Ser Thr Tyr Ile Leu Val Pro Leu Ser His 
1               5                   10                  


<210> 35
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 35
Ala Glu Thr Glu Asn Phe Val 
1               5           


<210> 36
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 36
Arg Ala Arg His Arg Arg Asn Val Asp Arg Val Ser Ile Gly Ser Tyr 
1               5                   10                  15      


Arg Thr 
        


<210> 37
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 37
Tyr Glu Asp Gln 
1               


<210> 38
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 38
Leu Leu Val Thr Ser Leu Leu Leu Cys Glu Leu Pro His Pro Ala Phe 
1               5                   10                  15      


Leu Ile Pro 
            


<210> 39
<211> 11
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<220>
<223> Description of Combined DNA/RNA Molecule: Synthetic
      oligonucleotide

<400> 39
aaaaaaaaaa a                                                            11


